FGF23 deficiency ameliorates progression of chronic kidney disease in mice.

被引:0
|
作者
Andrukhova, Olena [1 ]
Slavic, Svetlana [2 ]
Murali, Sathish Kumar [2 ]
Erben, Reinhold [3 ]
机构
[1] Inst Physiol Pathophysiol & Biophysics, Vienna, Austria
[2] Univ Vet Med, Biomed Sci 1Dept, Vienna, Austria
[3] Univ Vet Med, Vienna, Austria
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
MO0134
引用
收藏
页码:S390 / S390
页数:1
相关论文
共 50 条
  • [31] FGF23 neutralization improves bone quality and osseointegration of titanium implants in chronic kidney disease mice
    Sun, Ningyuan
    Zhang, Shiwen
    Zou, Huawei
    Shalhoub, Victoria
    Erben, Reinhold
    Yuan, Quan
    Lanske, Beate
    JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28
  • [32] Klotho, FGF23, and FGF receptors in chronic kidney disease: a yin-yang situation?
    Drueeke, Tilman B.
    KIDNEY INTERNATIONAL, 2010, 78 (11) : 1057 - 1060
  • [33] Lipocalin-2 Regulates FGF23 Production in Chronic Kidney Disease
    Courbon, Guillaume
    Francis, Connor
    Gerber, Claire
    Neuburg, Samantha
    Capella, Maralee
    Wang, Xueyan
    Martin, Aline
    David, Valentin
    JOURNAL OF BONE AND MINERAL RESEARCH, 2019, 34 : 15 - 15
  • [34] Model-Based Analysis of FGF23 Regulation in Chronic Kidney Disease
    Yokota, Hiroki
    Pires, Ana
    Raposo, Joao F.
    Ferreira, Hugo G.
    GENE REGULATION AND SYSTEMS BIOLOGY, 2010, 4 : 53 - 60
  • [35] FGF23 adds value to risk prediction in patients with chronic kidney disease
    Smith, Edward R.
    Ford, Martin L.
    Tomlinson, Laurie A.
    McMahon, Lawrence P.
    Rajkumar, Chakravarthi
    Holt, Stephen G.
    BONE, 2012, 51 (04) : 830 - 831
  • [36] The Pathogenesis of the Mechanism of FGF23 in Chronic Kidney Disease Patients with Vascular Calcification
    Shanshan LI
    Wenyu GNOG
    Sibo HUANG
    Lianghong YIN
    Bo HU
    Xiangnan DONG
    Taksui WONG
    Fanna LIU
    Yingyan LI
    Yueling ZHU
    Xin CHEN
    Baozhang GUAN
    Shengling HUANG
    Shuang CUI
    Bing YAN
    Hongwei HU
    Shaofeng HUANG
    Yongpin LU
    Shufei ZENG
    Chen YUN
    Berthold Hocher
    Wolfgang Pomme
    临床医学工程, 2017, (S1) : 49 - 51
  • [37] Cardiac hypertrophy in chronic kidney disease-role of Aldosterone and FGF23
    Hayashi K.
    Suzuki T.
    Sakamaki Y.
    Ito S.
    Renal Replacement Therapy, 4 (1)
  • [38] FGF23, IRON STATUS AND VITAMIN D METABOLISM IN CHRONIC KIDNEY DISEASE
    Piec, Isabelle
    Chipchase, Allison
    Nicholls, Holly
    Washbourne, Christopher
    Tang, Jonathan
    Fraser, William D.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 1460 - 1460
  • [39] NOVEL ELISA FOR THE DETECTION OF INTACT FGF23 IN PATIENTS WITH CHRONIC KIDNEY DISEASE
    Wallwitz, Jacqueline
    Elisabeth, Gadermaier
    Gabriela, Berg
    Gottfried, Himmler
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 : 466 - U637
  • [40] FIBROBLAST GROWTH FACTOR 23 (FGF23) AND DIASTOLIC DYSFUNCTION IN PAEDIATRIC CHRONIC KIDNEY DISEASE
    Koh, Chee Teck
    Lu, Liangjian David
    Teo, Sher Leen Sharon
    Than, Mya
    Lau, Yew Weng Perry
    Quek, Swee Chye
    Ling, Lieng Hsi
    Gong, Lingli
    Chen, Ching Kit
    Ng, Kar Hui
    Liu, Desheng Isaac
    Yap, Hui Kim
    PEDIATRIC NEPHROLOGY, 2021, 36 (09) : 2944 - 2944